Article Text


THU0002 Il-10 and il-6 polymorphisms are not related to erosive disease in early rheumatoid arthritis
  1. C Orellana1,
  2. R Sanmartí1,
  3. JD Cañete1,
  4. J Yagüe2,
  5. G Ercilla2,
  6. A Gómez1,
  7. G Salvador1,
  8. J Muñoz-Gómez1
  1. 1Department of Rheumatology
  2. 2Department of Immunology, Hospital Clínic, Barcelona, Spain


Objectives To assess the prevalence of IL-10 and IL-6 polymorphisms in patients with early rheumatoid arthritis (RA) in our population and investigate whether there is an association with radiographic severity.

Methods 68 patients with early RA (49F/19M, mean age 51 ± 15 y, mean disease duration 15 ± 13 mo, RF+ 72%, mean number of swollen joints at entry 8.23 ± 7.33). Patients were genotyped for HLA-DRB1 and IL-10 and IL-6 alleles and results compared with the control population (n = 110). Hands and feet radiographs were taken at entry and then yearly during follow-up. The Larsen method was used to assess radiographic damage.

Results There were not differences in the distribution of IL-6 alleles in the RA patients compared with controls. A difference was found in the distribution of IL-10 polymorphism at position ?592 between patients with RA and the control population: 592CC, 592CA and 592AA were found in a 40%, 54% and 6% of patients with RA versus a 55%, 33% and 12% respectively among controls (p = 0.018). No other differences were found in the frequency of the IL-10 alleles between RA and controls. No associations related to IL-6 or IL-10 polymorphisms were found in relation to radiographic damage.

Conclusion The IL-10 polymorphism at position ?592 showed a greater proportion of the CA allele in AR compared with the control population, although the clinical implications if any of this difference remains to be determined. No IL-6 nor any other IL-10 polymorphisms either were found to be associated to RA. No IL-10 nor IL-6 polymorphisms were found to be related to erosive disease in early rheumatoid arthritis.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.